Physician profile
Luis Godreau
NPI 1497852461
$1,360.03
in general payments reported to CMS, 2019-2025
9 companies · $467 in 2025
The $467 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.95 · 2020: $17.54 · 2021: $75.94 · 2022: $182 · 2023: $165 · 2024: $437 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $662.70 | 2022-2025 | Thinprep 2000 Processor, Aptima, Third Wave |
| Roche Diagnostics Corporation | $270.00 | 2024-2025 | Cobas 4800 Ct/Ng Test V2.0, Cintec Plus Cytology |
| Olympus Latin America, INC. | $144.47 | 2020-2023 | Olympus |
| Bard Peripheral Vascular, INC. | $123.90 | 2022 | |
| Boston Scientific Corporation | $75.94 | 2021 | |
| Organon LLC | $28.53 | 2025 | Nexplanon |
| Pbg Puerto Rico LLC | $23.65 | 2023 | |
| Medtronic, INC. | $15.95 | 2019 | |
| Glaxosmithkline, LLC. | $14.89 | 2023 | Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Godreau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.